ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China flag China · Delayed Price · Currency is CNY
29.78
-0.42 (-1.39%)
Nov 6, 2026, 3:04 PM CST

SHE:300723 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,129515.38468.97422.52645.61,075
Short-Term Investments
---1--
Trading Asset Securities
24-4.7540.4472.1915.03
Cash & Short-Term Investments
1,153515.38473.72463.96717.781,090
Cash Growth
57.71%8.79%2.10%-35.36%-34.15%47.50%
Accounts Receivable
167.38242.2351.1451.38397.75243.39
Other Receivables
40.740.111.2412.4812.427.16
Receivables
208.08282.31362.34463.86410.15270.55
Inventory
191.98215.91287.13346.44178.02114.97
Prepaid Expenses
-2.3822.681.02--
Other Current Assets
172.4585112.0284.58105.3788.02
Total Current Assets
1,7251,1011,2581,3601,4111,564
Property, Plant & Equipment
1,6861,7901,9281,7991,6861,043
Long-Term Investments
284.19525.57583.44633.55384.44408.01
Goodwill
0.260.260.2611.2811.2811.28
Other Intangible Assets
358.68390.19428.46446.79460.97460.42
Long-Term Deferred Tax Assets
152.83137.5129.1354.3447.3236.71
Long-Term Deferred Charges
89.4389.0959.3756.159.5358.53
Other Long-Term Assets
18.298.9817.3744.7837.08146.58
Total Assets
4,3154,0424,4044,4054,0983,728

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
63.7482.04107.84202.484.8340.65
Accrued Expenses
18.5549.0648.18126.2877.6573.15
Short-Term Debt
795.15520.081,000550550851.66
Current Portion of Long-Term Debt
31.31181.3460.29402.231.56
Current Portion of Leases
-1.7917.6326.3925.4923.06
Current Income Taxes Payable
13.74--37.8127.936.41
Current Unearned Revenue
17.9936.5738.848.37110.3620.99
Other Current Liabilities
253.67264.77459.5457.73330.37188.21
Total Current Liabilities
1,1941,1361,7321,4891,2091,206
Long-Term Debt
1,1901,368610160531.42270.45
Long-Term Leases
1.431.432.826.0358.5282.33
Long-Term Unearned Revenue
110.32108.9687.5483.3475.7684.45
Long-Term Deferred Tax Liabilities
16.6921.1435.4949.0158.0966.82
Total Liabilities
2,5132,6362,4681,8071,9331,710

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
453.18451.69451.69454.14288.08288.03
Additional Paid-In Capital
624.52592.8682.13814.15542.26570.59
Retained Earnings
847.15464.49802.291,4371,3091,075
Treasury Stock
-155.73-139.63-57.66-182.82-192.6-169
Comprehensive Income & Other
----104.82110.14
Total Common Equity
1,7691,3691,8782,5222,0511,874
Minority Interest
33.3637.3457.4375.83114.59144.07
Shareholders' Equity
1,8021,4071,9362,5982,1662,018
Total Liabilities & Equity
4,3154,0424,4044,4054,0983,728

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
2,0182,0731,691802.431,1681,229
Net Cash (Debt)
-865.25-1,558-1,217-338.46-449.87-139.01
Net Cash Growth
------
Net Cash Per Share
-1.91-3.45-2.69-0.75-1.04-0.33
Filing Date Shares Outstanding
456.09451.91451.65449.03424.45426.18
Total Common Shares Outstanding
456.09451.91451.65449.03424.45426.18
Working Capital
531.08-34.66-474.5-129.13202.47357.9
Book Value Per Share
3.883.034.165.624.834.40
Tangible Book Value
1,410978.91,4502,0641,5791,403
Tangible Book Value Per Share
3.092.173.214.603.723.29
Buildings
-1,2171,1801,039615.9575.71
Machinery
-1,093981.26820.5272.02244.21
Construction In Progress
-8.09141.94164.02904.37783.68